Skip Navigation

Where I see Valeant in 2 years: Biogen chairman

In this video

Where I see Valeant in 2 years: Biogen chairman

Discussion on Valeant's worth and the company's struggles with Stelios Papadopoulos, Biogen chairman.

04:55

Fri, May 27 20165:30 PM EDT

Earnings will make new record highs over the next few quarters, says Ed Yardeni

Earnings will make new record highs over the next few quarters, says Ed Yardeni

Charles Schwab's Kevin Gordon: More weakness in the labor market needs to happen for a Fed cut

Charles Schwab's Kevin Gordon: More weakness in the labor market needs to happen for a Fed cut

Google's fate hinges on this man: Demis Hassabis

Google's fate hinges on this man: Demis Hassabis

Austin Ekeler on joining the Washington Commanders

Austin Ekeler on joining the Washington Commanders

The Fed on rate cut timeline, restrictive monetary policy and inflation target

The Fed on rate cut timeline, restrictive monetary policy and inflation target

Earnings will make new record highs over the next few quarters, says Ed Yardeni

Earnings will make new record highs over the next few quarters, says Ed Yardeni

Charles Schwab's Kevin Gordon: More weakness in the labor market needs to happen for a Fed cut

Charles Schwab's Kevin Gordon: More weakness in the labor market needs to happen for a Fed cut

Google's fate hinges on this man: Demis Hassabis

Google's fate hinges on this man: Demis Hassabis

Austin Ekeler on joining the Washington Commanders

Austin Ekeler on joining the Washington Commanders

The Fed on rate cut timeline, restrictive monetary policy and inflation target

The Fed on rate cut timeline, restrictive monetary policy and inflation target